Sermorelin 5mg (10 vials/kit): Growth Hormone Releasing Hormone (GHRH) Analog for Somatotroph Research

Sermorelin (GHRH 1-29 amide) is a synthetic 29-amino-acid peptide corresponding to the amino-terminal functional domain of naturally occurring human growth hormone-releasing hormone ($\text{GHRH}_{1-44}$). Exhibiting the chemical sequence $\text{H-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH}_2$, Sermorelin functions as a selective agonist at the pituitary GHRH receptor ($\text{GHRH-R}$). By binding GHRH receptors on pituitary somatotrophs, Sermorelin stimulates the endogenous synthesis and pulsatile release of growth hormone ($\text{GH}$). Sourcing Sermorelin 5mg (10 vials/kit) provides endocrinologists, molecular biologists, and preclinical researchers with a high-purity analytical reagent engineered to investigate pituitary secretagogue dynamics, somatotroph signaling cascades, and age-related growth hormone axis decline.

Unlike exogenous recombinant human growth hormone ($\text{rhGH}$), which bypasses endogenous regulatory control and suppresses pituitary somatotroph activity through direct feedback inhibition, Sermorelin operates higher up the neuroendocrine cascade. By acting on the pituitary gland, Sermorelin preserves the native hypothalamic-pituitary-somatotropic axis. This activation stimulates the release of growth hormone in natural physiological pulses while maintaining sensitivity to endogenous somatostatin (growth hormone-inhibiting hormone, $\text{GHIH}$) negative feedback loops. Consequently, Sermorelin serves as an ideal bio-analytical model for studying physiological GH secretagogue kinetics without inducing somatotroph desensitization or complete suppression of endogenous regulatory circuits.

Maintaining structural stability and batch uniformity is essential for quantitative neuroendocrine bioassays and receptor-binding kinetics. The Sermorelin 5mg (10 vials/kit) configuration supplies a total yield of 50mg active peptide material (5mg per vial) distributed across ten individual USP Type I borosilicate glass vials. Freeze-dried under sterile vacuum conditions, each vial contains a highly stable lyophilized powder cake. This multi-vial kit structure enables research personnel to reconstitute only the working volume needed for immediate experimental trials, keeping remaining vials protected in sub-zero storage from ambient moisture and thermal degradation.

GHRH Signaling, Pituitary Axis Dynamics, and Technical Profile

The primary scientific value of Sermorelin 5mg (10 vials/kit) stems from its targeted interaction with pituitary GHRH receptors and downstream neuroendocrine pathways:

• Pituitary GHRH-R Agonism: Binds specifically to GHRH receptors on anterior pituitary somatotrophs, stimulating adenylate cyclase and increasing intracellular cyclic adenosine monophosphate ($\text{cAMP}$) levels to trigger GH gene transcription and exocytosis.

• Pulsatile GH Secretion: Mimics natural hypothalamic GHRH secretion patterns, driving physiological GH release pulses rather than static, un-pulsed systemic elevations.

• Preservation of Negative Feedback Loops: Maintains sensitivity to somatostatin ($\text{GHIH}$) and insulin-like growth factor 1 ($\text{IGF-1}$) negative feedback, preventing supra-physiological GH spikes in preclinical models.

• IGF-1 Downstream Regulation: Indirectly stimulates hepatic synthesis and systemic secretion of $\text{IGF-1}$, facilitating the study of downstream cell growth, tissue remodeling, and metabolic bio-assays.

• Truncated N-Terminal Sequence: Contains the shortest fully active fragment (amino acids 1–29) of native $\text{GHRH}_{1-44}$ required for complete biological activity at the receptor site.

• Ultra-High Chemical Purity ($\ge$99.0%): Synthesized via automated Solid-Phase Peptide Synthesis ($\text{SPPS}$) and purified using preparative High-Performance Liquid Chromatography ($\text{HPLC}$) to ensure complete removal of deletion sequences and synthesis byproducts.

Reconstitution Guidelines, Laboratory Storage Standards, and Quality Protocols

Achieving reproducible, publication-grade results when working with Sermorelin 5mg (10 vials/kit) requires strict adherence to standardized aseptic reconstitution and climate-controlled storage procedures.

Perform all reconstitution procedures inside a certified Class II Biosafety Cabinet:

1. Temperature Balancing: Allow the frozen Sermorelin 5mg (10 vials/kit) vial to adjust to ambient room temperature prior to solvent introduction to eliminate condensation inside the glass container.

2. Septum Sanitization: Remove the protective plastic flip-cap and thoroughly wipe the synthetic rubber stopper with a fresh 70% isopropyl alcohol pad. Allow the surface to air-dry completely.

3. Slow Diluent Addition: Using a sterile syringe equipped with a fine-gauge needle, draw the required volume of Bacteriostatic Water (0.9% benzyl alcohol), Sterile Normal Saline (0.9% NaCl), or Phosphate-Buffered Saline (PBS). Direct the liquid stream against the inner glass wall so it trickles slowly over the lyophilized cake.

4. Gentle Hydration: Allow the diluent to fully hydrate the powder cake for 2 to 3 minutes. Gently roll the vial between your palms or swirl in smooth circular motions until clear. Never vortex or shake vigorously, as high-shear agitation can disrupt peptide bonds and induce protein foaming.

5. Aliquoting Strategy: For extended testing protocols, divide reconstituted liquid into sterile, single-use microcentrifuge tubes under aseptic conditions to prevent atmospheric oxidation and eliminate repeated freeze-thaw cycles.

Batch Quality Documentation & Traceability: Every production lot of Sermorelin 5mg (10 vials/kit) undergoes third-party analytical testing. High-Performance Liquid Chromatography (HPLC) chromatograms confirm component purity exceeding 99.0%, while Electrospray Ionization Mass Spectrometry (ESI-MS) confirms precise theoretical molecular mass. Each shipment includes a batch-specific Certificate of Analysis (COA) documenting chemical purity, residual solvent analysis, heavy metal screens, and bacterial endotoxin levels (<0.05 EU/mg) to satisfy institutional compliance requirements.

Strict Regulatory & Research Compliance Statement: Sermorelin 5mg (10 vials/kit) is produced, packaged, and distributed exclusively for in vitro laboratory research, academic experimentation, chemical synthesis, and preclinical research. Sermorelin 5mg (10 vials/kit) is strictly not intended, formulated, or approved for human or animal consumption, therapeutic medical treatment, clinical diagnostic work, or cosmetic applications. All handling must be conducted by certified research personnel operating within equipped laboratory facilities in compliance with OSHA workplace safety regulations and institutional biosafety protocols.